![Ingrid Jonsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Ingrid Jonsson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Strandbacka Medical
![]() Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Fundador | 01/01/2020 | - |
Corporate Officer/Principal | 01/01/2020 | - |
Historial de carrera de Ingrid Jonsson
Estadísticas
Internacional
Suecia | 2 |
Operativa
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Strandbacka Medical
![]() Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Ingrid Jonsson
- Experiencia